Taragarestrant

Modify Date: 2024-01-13 19:08:57

Taragarestrant structure	Common Name	Taragarestrant
	CAS Number	2118899-51-5	Molecular Weight	475.38
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₅H₂₅Cl₂FN₂O₂	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Taragarestrant

Taragarestrant (D-0502) is a potent, orally active estrogen receptor degrader. Taragarestrant has antiproliferative activity against estrogen receptor-positive breast cancer cell lines and has anticancer activity. Taragarestrant can be used for cancer research[1][2].

Name	Taragarestrant

Description	Taragarestrant (D-0502) is a potent, orally active estrogen receptor degrader. Taragarestrant has antiproliferative activity against estrogen receptor-positive breast cancer cell lines and has anticancer activity. Taragarestrant can be used for cancer research[1][2].
Related Catalog	Signaling Pathways >> Others >> Estrogen Receptor/ERR Research Areas >> Cancer
References	[1]. Lin WY, et, al. Abstract 5776: Pharmacologic and PK/PD study of D-0502: An orally bioavailable SERD with potent antitumor activity in ER-positive breast cancer cell lines and xenograft models. 2018 Jul 1;78(13):5776. [2]. WHO Drug Information. International Nonproprietary Names for Pharmaceutical

Description

Related Catalog

Signaling Pathways >> Others >> Estrogen Receptor/ERR

Research Areas >> Cancer

References

[1]. Lin WY, et, al. Abstract 5776: Pharmacologic and PK/PD study of D-0502: An orally bioavailable SERD with potent antitumor activity in ER-positive breast cancer cell lines and xenograft models. 2018 Jul 1;78(13):5776.

[2]. WHO Drug Information. International Nonproprietary Names for Pharmaceutical